Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 131
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Biotechnol Bioeng ; 119(9): 2494-2504, 2022 09.
Artículo en Inglés | MEDLINE | ID: mdl-35750654

RESUMEN

In high-performance industrial fermentation processes, stirring and aeration may account for significant production costs. Compared to the widely applied Rushton impellers, axial-pumping impellers are known to yield a lower power draw and at the same time improve mixing. However, their lower gas dispersion capability requires stronger agitation, compromising these benefits. Diverse advanced impeller forms have been developed to cope with this challenge. We apply alternating radial and axial impellers and demonstrate strong gas dispersion and energy-efficient mixing for the first time in a large-scale (160 m3 ) bioreactor, based on experimental and computational fluid dynamics simulation data. For equal operating conditions (stirrer speed, aeration rate), this setup yielded similar gas hold-ups and better mixing times (35%) compared to a classical Rushton-only configuration. Hence, applying a radial impeller on an upper level for improving gas dispersion maintains the benefits of axial impellers in terms of reducing energy demand (up to 50%). We conclude that this effect is significant only at large-scale, when bubbles substantially expand due to the release of the hydrostatic pressure and have time to coalesce. The work thus extends current knowledge on mixing and aeration of large-scale reactors using classical impeller types.


Asunto(s)
Reactores Biológicos , Hidrodinámica , Simulación por Computador , Fermentación
2.
AAPS PharmSciTech ; 23(7): 264, 2022 Sep 26.
Artículo en Inglés | MEDLINE | ID: mdl-36163535

RESUMEN

Microparticulate drug delivery systems, e.g., micropellets (MPs), are used in a variety of pharmaceutical formulations such as suspensions, injectable systems, and capsules. MPs are currently manufactured mainly via batch, solvent-based processes, e.g., spray-drying and solvent evaporation-extraction. In this paper, we present a novel, solvent-free, continuous hot-melt extrusion-based approach with an inline cold pelletization step and the potential of unprecedented on-the-fly formulation changes, aiming at producing the smallest particles usable for injectable applications. A biodegradable, crystalline dispersion consisting of poly(DL-lactic acid) (PLA) filled with metformin as the model drug was chosen on purpose to elucidate the broad applicability of the process also to formulations with limited stretchability and complex pelletizability. Next to optical/statistical particle analyses and in-line high-speed camera investigations providing insights into the pelletization process, the injectability of the most promising micropellets was compared to that of one marketed formulation. Fast extrudate haul-off speeds and high numbers of pelletizer knives resulted in particles with a narrow and small particle size distribution with a d50 below 270 µm and aspect ratios close to 1. To omit protruding drug particles to ensure sufficient extrudate stretchability and allow for the smallest MPs, it was found that the d90 of the embedded drug must be significantly below the extrudate diameter. Upon adapting the syringe diameter, the produced micropellets revealed similar injectability parameters to the marketed formulation, showcasing the potential that the proposed setup has for the manufacturing of novel microparticulate formulations.


Asunto(s)
Ácido Láctico , Metformina , Composición de Medicamentos/métodos , Calor , Poliésteres , Solubilidad , Suspensiones
3.
Biotechnol Bioeng ; 118(8): 3058-3068, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-33990949

RESUMEN

Multiple impeller reactors are widely used due to their advanced gas utilization and an increased volumetric mass transfer coefficient. However, with the application of Rushton impellers, gas dispersion efficiency varies between the bottom and the upper impeller levels. The present study analyzes the individual flow regime, power input, and gas hold-up in each compartment of a reactor equipped with four Rushton impellers. The results indicate that the pre-dispersion of the air introduced by the bottom impeller (up to 80%) plays a key role in a better gas retention efficiency of the upper impellers (>300%) and leads to a shift of the cavity and flooding lines in the flow map (Fr- vs Fl-Number) of the upper impellers. A novel analysis of the bubble flow in the dispersed state via a two-phase LES-based CFD model reveals that a more homogenous distribution of air bubbles in the upper compartments leads to high compartment gas hold-up values, but fewer bubbles in the vicinity of the impellers. The measured and simulated data of this study indicate that the upper impellers' efficiency mostly depends on the flow regime of and the pre-dispersion by the bottom impeller rather than on the upper impellers' flow regimes. These results contribute to the understanding of essential mixing processes and scaling of aerated bioreactors.


Asunto(s)
Aire , Reactores Biológicos , Diseño de Equipo , Modelos Químicos
4.
AAPS PharmSciTech ; 22(6): 211, 2021 Aug 10.
Artículo en Inglés | MEDLINE | ID: mdl-34374899

RESUMEN

This study evaluates the potential use of near-infrared hyperspectral imaging (NIR-HSI) for quantitative determination of the drug amount in inkjet-printed dosage forms. We chose metformin hydrochloride as a model active pharmaceutical ingredient (API) and printed it onto gelatin films using a piezoelectric inkjet printing system. An industry-ready NIR-HSI sensor combined with a motorized movable linear stage was applied for spectral acquisition. Initial API-substrate screening revealed best printing results for gelatin films with TiO2 filling. For calibration of the NIR-HSI system, escalating drug doses were printed on the substrate. After spectral pre-treatments, including standard normal variate (SNV) and Savitzky-Golay filtering for noise reduction and enhancement of spectral features, principal component analysis (PCA) and partial least squares (PLS) regression were applied to create predictive models for the quantification of independent printed metformin hydrochloride samples. It could be shown that the concentration distribution maps provided by the developed HSI models were capable of clustering and predicting the drug dose in the formulations. HSI model prediction showed significant better correlation to the reference (HPLC) compared to on-board monitoring of dispensed volume of the printer. Overall, the results emphasize the capability of NIR-HSI as a fast and non-destructive method for the quantification and quality control of the deposited API in drug-printing applications.


Asunto(s)
Imágenes Hiperespectrales , Espectroscopía Infrarroja Corta , Composición de Medicamentos , Análisis de los Mínimos Cuadrados , Control de Calidad
5.
AAPS PharmSciTech ; 22(7): 247, 2021 Oct 12.
Artículo en Inglés | MEDLINE | ID: mdl-34642863

RESUMEN

This paper proposes a feed rate control strategy for a novel volumetric micro-feeder, which can accomplish low-dose feeding of pharmaceutical raw materials with significantly different powder properties. The developed feed-forward control strategy enables a constant feed rate with a minimum deviation from the set-point, even for materials that are typically difficult to accurately feed (e.g., due to high cohesion or low density) using conventional continuous feeders. Density variations observed during the feeding process were characterized via a displacement feed factor profile for each powder. The characterized effective displacement density profile was applied in the micro-feeder system to proactively control the feed rate by manipulating the powder displacement rate (i.e., computing the feed rate from the powder displacement rate). Based on the displacement feed factor profile, the feed rate can be predicted during the feeding process and at any feed rate set-point. Three pharmaceutically relevant materials were used for the micro-feeder evaluation: di-calcium phosphate (large-particle system, high density), croscarmellose sodium (small-particle system, medium density), and barium sulfate (very small-particle <10 µm, high density). A significant improvement in the feeding performance was achieved for all investigated materials. The feed rate deviation from the set-point and its relative standard deviation were minimal compared to operations without the control strategy.


Asunto(s)
Tecnología Farmacéutica , Polvos
6.
Drug Dev Ind Pharm ; 46(5): 775-787, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32290729

RESUMEN

We studied three lactose-based formulations in terms of bulk powder properties and capsule-filling behavior in a tamping-pin capsule filling system, to which several mechanical adaptions were made for process optimization in light of future continuous production. The model formulations were thoroughly characterized and filled into size 1 capsules according a well-defined design of experiments (DoE). Overall, the three entirely different formulations were successfully filled within the selected design space. The fill weight and fill weight variability can be adjusted by fine-tuning the process settings, like the pin immersion depth and the maximum compaction pressure (pneumatic or spring-controlled), and by using the appropriate powder bed height and mechanical adaptions. This study demonstrated that selection of process parameters and mechanical adaptions could enhance the filling performance, especially in continuous production, since they reduce the powder volume in the process. Moreover, we showed that a tamping-pin system is capable of successfully filling a broad range of powders with various material characteristics and can potentially be used in a continuous production mode.


Asunto(s)
Química Farmacéutica/instrumentación , Química Farmacéutica/métodos , Composición de Medicamentos/métodos , Lactosa/síntesis química , Cápsulas , Polvos
7.
AAPS PharmSciTech ; 22(1): 10, 2020 Nov 26.
Artículo en Inglés | MEDLINE | ID: mdl-33244725

RESUMEN

Continuous manufacturing is increasingly used in the pharmaceutical industry, as it promises to deliver better product quality while simultaneously increasing production flexibility. GEA developed a semi-continuous tablet coater which can be integrated into a continuous tableting line, accelerating the switch from traditional batch production to the continuous mode of operation. The latter offers certain advantages over batch production, e.g., operational flexibility, increased process/product quality, and decreased cost. However, process understanding is the key element for process control. In this regard, computational tools can improve the fundamental understanding and process performance, especially those related to new processes, such as continuous tablet coating where process mechanics remain unclear. The discrete element method (DEM) and computational fluid dynamics (CFD) are two methods that allow transition from empirical process design to a mechanistic understanding of the individual process units. The developed coupling model allows to track the heat, mass, and momentum exchange between the tablet and fluid phase. The goal of this work was to develop and validate a high-fidelity CFD-DEM simulation model of the tablet coating process in the GEA ConsiGma® coater. After the model development, simulation results for the tablet movement, coating quality, and heat and mass transfer during the coating process were validated and compared to the experimental outcomes. The experimental and simulation results agreed well on all accounts measured, indicating that the model can be used in further studies to investigate the operating space of the continuous tablet coating process.


Asunto(s)
Simulación por Computador , Preparaciones Farmacéuticas , Reproducibilidad de los Resultados , Comprimidos
8.
AAPS PharmSciTech ; 21(8): 301, 2020 Nov 03.
Artículo en Inglés | MEDLINE | ID: mdl-33141336

RESUMEN

Highly potent active pharmaceutical ingredients (APIs) and low-dose excipients, or excipients with very low density, are notoriously hard to feed with currently available commercial technology. The micro-feeder system presented in this work is capable of feeding low-dose rates of powders with different particle sizes and flow properties. Two different grades of lactose, di-calcium phosphate, croscarmellose sodium, silicon dioxide, a spray-dried intermediate, and an active ingredient were studied to vary material properties to test performance of the system. The current micro-feeder system is a volumetric feeder combined with a weighing balance at the outlet that measures feeder output rates. Feeding results are shown as a so-called "displacement-feed factor" curve for each material. Since the powder mass and volume are known in the micro-feeder system, in this work, we characterized an observed density variation during processing via a "displacement-feed factor" profile for each of the fed powders. This curve can be later used for calibrating the system to ensure an accurate, constant feed rate and in addition predicting feeding performance for that material at any feed rate. There is a relation between powder properties and feeding performance. Powders with finer particles and higher compressibility show densification during their feeding process. However, powders with larger particles and lower compressibility show both "densification" and "powder bed expansion," which is the manifestation of dilation and elastic recovery of particles during the micro-feeding process. Through the application of the displacement-feed factor, it is possible to provide precise feeding accuracy of low-dose materials.


Asunto(s)
Polvos , Tecnología Farmacéutica/métodos , Calibración , Excipientes , Lactosa/química , Tamaño de la Partícula
9.
AAPS PharmSciTech ; 21(5): 176, 2020 Jun 22.
Artículo en Inglés | MEDLINE | ID: mdl-32572701

RESUMEN

This paper presents a rational workflow for developing enabling formulations, such as amorphous solid dispersions, via hot-melt extrusion in less than a year. First, our approach to an integrated product and process development framework is described, including state-of-the-art theoretical concepts, modeling, and experimental characterization described in the literature and developed by us. Next, lab-scale extruder setups are designed (processing conditions and screw design) based on a rational, model-based framework that takes into account the thermal load required, the mixing capabilities, and the thermo-mechanical degradation. The predicted optimal process setup can be validated quickly in the pilot plant. Lastly, a transfer of the process to any GMP-certified manufacturing site can be performed in silico for any extruder based on our validated computational framework. In summary, the proposed workflow massively reduces the risk in product and process development and shortens the drug-to-market time for enabling formulations.


Asunto(s)
Química Farmacéutica , Calor , Composición de Medicamentos , Modelos Químicos , Solubilidad
10.
Drug Dev Ind Pharm ; 45(9): 1523-1536, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31215822

RESUMEN

The aim of this work was to investigate the mean fill weight control of a continuous capsule-filling process, whether it is possible to derive controller settings from an appendant process model. To that end, a system composed out of fully automated capsule filler and an online gravimetric scale was used to control the filled weight. This setup allows to examine challenges associated with continuous manufacturing processes, such as variations in the amount of active pharmaceutical ingredient (API) in the mixture due to fluctuations of the feeders or due to altered excipient batch qualities. Two types of controllers were investigated: a feedback control and a combination of feedback and feedforward control. Although both of those are common in the industry, determining the optimal parameter settings remains an issue. In this study, we developed a method to derive the control parameters based on process models in order to obtain optimal control for each filled product. Determined via rapid automated process development (RAPD), this method is an effective and fast way of determining control parameters. The method allowed us to optimize the weight control for three pharmaceutical excipients. By conducting experiments, we verified the feasibility of the proposed method and studied the dynamics of the controlled system. Our work provides important basic data on how capsule filler can be implemented into continuous manufacturing systems.


Asunto(s)
Composición de Medicamentos/métodos , Modelos Teóricos , Control de Calidad , Cápsulas , Composición de Medicamentos/normas , Excipientes , Estudios de Factibilidad , Polvos
11.
Pharm Dev Technol ; 24(6): 775-787, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31023115

RESUMEN

This paper addresses the relevance of automated content testing for the rapid automated process development (RAPD). Our previous work demonstrated that RAPD allowed a fast and efficient development of a continuous capsule-filling process. Target was the mean weight and the relative standard deviation of the weight. Likewise important are the content and the content uniformity. However, an implementation demands a certain level of automation. In general, technology is available that can detect active pharmaceutical ingredient (API) inside the capsules but the final application is linked to additional development and investment in machinery. To eliminate doubts regarding the benefits of an automated content check within the RAPD we present an application example. First, an X-ray system was used to detect barium sulfate accurately inside capsules. Second, a process was developed where barium sulfate was filled. The concentration of excipients was modified in the experiments, as well as the setting of the process parameter. The obtained model provided an explicit understanding of the process. Subsequently, the content uniformity model was compared to a model of the capsule weight relative standard deviation, confirming the benefits of an automated content check in the RAPD. Moreover, we presented another example illustrating the advantages of a connected continuous filling process, which permits evaluation of all process steps and their interactions (i.e. evaluation of the entire process).


Asunto(s)
Sulfato de Bario/análisis , Composición de Medicamentos/métodos , Excipientes/química , Gelatina/química , Cápsulas/química , Composición de Medicamentos/economía , Radiografía/economía , Radiografía/métodos , Tecnología Farmacéutica/economía , Tecnología Farmacéutica/métodos , Factores de Tiempo , Rayos X
12.
Pharm Dev Technol ; 24(6): 739-750, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-30821571

RESUMEN

An undesirable characteristic in lyophilized parenteral products is the potential presence of particulate matter in the final product, which may affect patient safety. In this study, quality risk management tools described in the International Conference on Harmonization Guideline Q9 were used to estimate the risks for a pharmaceutical manufacturing line, based on three critical quality attributes: (1) visible particulate matter; (2) lyo-cake collapse traces; and (3) lyo-cake melt-back traces. Together with a Process Failure Mode Effect Analysis (PFMEA), an input-output analysis of the individual unit operations identified seven major material classes of extrinsic particulate matter. In addition to the process assessment, an experimental investigation of the location of impurities in lyophilized products was performed. To that end, intentionally contaminated vials were examined to locate the particulate matter and its possible migration. The results emphasize the importance of a full transmission mode release testing since the particles may enter the interior of the lyo-cake. A theoretical explanation of the observed impurity locations is provided.


Asunto(s)
Contaminación de Medicamentos , Liofilización/métodos , Material Particulado/análisis , Preparaciones Farmacéuticas/química , Contaminación de Medicamentos/prevención & control , Embalaje de Medicamentos/métodos , Embalaje de Medicamentos/normas , Liofilización/normas , Control de Calidad
13.
Pharm Res ; 35(7): 135, 2018 May 07.
Artículo en Inglés | MEDLINE | ID: mdl-29736628

RESUMEN

PURPOSE: The effect of different irradiation doses on the structure and activity of lyophilized powders of Hen Egg-White Lysozyme (HEWL) and alcohol dehydrogenase (ADH) was investigated using these substances as models for robust and sensitive proteins, respectively. Three doses were selected to cover the ranges of radio-sterilization (25kGy), treatment of blood products (25Gy) and annual background radiation dose (approximately 2mGy). The results offer an initial screening of different irradiation doses and support the development of X-ray imaging methods as non-destructive process analytical technology (PAT) tools for detecting the visible particulate matters in such products. METHODS: HEWL and ADH were exposed to X-rays in the solid state. The effect of irradiation was determined directly after irradiation and after storage. Structural changes and degradation were investigated using SAXS, SDS-PAGE and HPLC-MS. Protein functionality was assessed via activity assays. RESULTS: Lower irradiation doses of 25Gy and 2mGy had no significant impact on the structure and enzyme activity. The dose of 25kGy caused a significant decrease in the enzyme activity and structural changes immediately after irradiation of ADH and after storage of irradiated HEWL at -20°C. CONCLUSION: The results emphasize the importance of careful selection of radiation doses for development of X-ray imaging methods as PAT tools inspection of solid biopharmaceutical products.


Asunto(s)
Alcohol Deshidrogenasa/química , Alcohol Deshidrogenasa/fisiología , Muramidasa/química , Muramidasa/fisiología , Dosis de Radiación , Alcohol Deshidrogenasa/efectos de la radiación , Animales , Muramidasa/efectos de la radiación , Dispersión del Ángulo Pequeño , Rayos X
14.
Clin Oral Investig ; 22(2): 929-940, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28691145

RESUMEN

OBJECTIVES: The design of nanocarriers for local drug administration to the lining mucosa requires a sound knowledge of how nanoparticles (NPs) interact with saliva. This contact determines whether NPs agglomerate and become immobile due to size- and interaction-filtering effects or adsorb on the cell surface and are internalized by epithelial cells. The aim of this study was to examine the behavior of NPs in saliva considering physicochemical NP properties. MATERIALS AND METHODS: The salivary pore-size distribution was determined, and the viscosity of the fluid inside of the pores was studied with optical tweezers. Distinct functionalized NPs (20 and 200 nm) were dispersed in saliva and salivary buffers and characterized, and surface-bound MUC5B and MUC7 were analyzed by 1D electrophoresis and immunoblotting. NP mobility was recorded, and cellular uptake studies were performed with TR146 cells. RESULTS: The mode diameter of the salivary mesh pores is 0.7 µm with a peak width of 1.9 µm, and pores are filled with a low-viscosity fluid. The physicochemical properties of the NPs affected the colloidal stability and mobility: compared with non-functionalized particles, which did not agglomerate and showed a cellular uptake rate of 2.8%, functionalized particles were immobilized, which was correlated with agglomeration and increased binding to mucins. CONCLUSION: The present study showed that the salivary microstructure facilitates NP adsorption. However, NP size and surface functionalization determine the colloidal stability and cellular interactions. CLINICAL RELEVANCE: The sound knowledge of NP interactions with saliva enables the improvement of current treatment strategies for inflammatory oral diseases.


Asunto(s)
Nanopartículas/química , Saliva/química , Adulto , Voluntarios Sanos , Humanos , Immunoblotting , Persona de Mediana Edad , Mucinas/química , Porosidad , Proteínas y Péptidos Salivales/análisis , Viscosidad
15.
Drug Dev Ind Pharm ; 44(3): 502-510, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29160723

RESUMEN

The aim of this paper is to explore the possibility to develop an automatically adjustable, reliable, and safe capsule filling operation. Process parameters that are critical for the tamping pin process were reviewed based on the literature and via experiment. Dosing disc height, powder bed height, machine speed, pressure on the tamping pin, and immersion depth were reviewed. Two investigations were performed on a GKF 702. In the first one, the powder feed rate onto the dosing disc was examined and modified. A distance sensor with a PID controller enabled a constant powder bed level with an online changeable set point. For a bad flowing product an improvement of the fill weight variation could be achieved by automatically adjusting the feed rate to the correct speed and matching the actual process conditions of the capsule filler. The second part of the study concerned the safety of the filler operation. Introducing a force transducer on the transfer station is a promising option for running the capsule filler safely within its process specifications. The tamping pin pressure was used to provoke different transfer forces. A deviation from a defined process specification led to a safe stop of the machine. In summary, the automated adjustment of several critical process parameters appears to be feasible and supports the rational development of efficient production processes using a dosing disc capsule filler. This is especially relevant for continuous production of pharmaceuticals.


Asunto(s)
Cápsulas/química , Automatización/métodos , Química Farmacéutica/métodos , Polvos/química , Presión , Reproducibilidad de los Resultados , Tecnología Farmacéutica/métodos
16.
Mol Pharm ; 14(12): 4560-4571, 2017 12 04.
Artículo en Inglés | MEDLINE | ID: mdl-29058913

RESUMEN

Understanding properties and mechanisms that govern drug degradation in the solid state is of high importance to ensure drug stability and safety of solid dosage forms. In this study, we attempt to understand drug-excipient interactions in the solid state using both theoretical and experimental approaches. The model active pharmaceutical ingredients (APIs) under study are carvedilol (CAR) and codeine phosphate (COP), which are known to undergo esterification with citric acid (CA) in the solid state. Starting from the crystal structures of two different polymorphs of each compound, we calculated the exposure and accessibility of reactive hydroxyl groups for a number of relevant crystal surfaces, as well as descriptors that could be associated with surface stabilities using molecular simulations. Accelerated degradation experiments at elevated temperature and controlled humidity were conducted to assess the propensity of different solid forms of the model APIs to undergo chemical reactions with anhydrous CA or CA monohydrate. In addition, for CAR, we studied the solid state degradation at varying humidity levels and also under mechano-activation. Regarding the relative degradation propensities, we found that variations in the exposure and accessibility of molecules on the crystal surface play a minor role compared to the impact of molecular mobility due to different levels of moisture. We further studied drug-excipient interactions under mechano-activation (comilling of API and CA) and found that the reaction proceeded even faster than in physical powder mixtures kept at accelerated storage conditions.


Asunto(s)
Carbazoles/química , Ácido Cítrico/química , Codeína/química , Excipientes/química , Propanolaminas/química , Carvedilol , Cristalización , Estabilidad de Medicamentos , Esterificación , Humedad , Polvos/química , Temperatura , Agua/química
17.
AAPS PharmSciTech ; 18(8): 2971-2976, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28462464

RESUMEN

Co-extrusion offers a number of advantages over conventional manufacturing techniques. However, the setup of a co-extrusion line is cost- and time-intense and formulation development is challenging. This work introduces a novel procedure to test the applicability of a co-extruded reservoir-type system at an early product development stage. We propose vacuum compression molding (VCM), a fast procedure that requires only small material amounts, for the manufacturing of cylindrical reservoir-type system. To this end, the commercially available co-extruded product NuvaRing® and variations thereof were used as test systems. All VCM systems showed a homogeneous skin thickness that adhered well to the core, thereby providing a precise core/skin interface. As drug release is a key criterion for pharmaceutical products, a modified in vitro dissolution method was set up to test the VCM systems. The drug release from the VCM systems was in the same order of magnitude as the corresponding co-extruded strands and followed the same release kinetics. Moreover, the VCM systems were capable of indicating the relative effect of formulation-related modifications on drug release. Overall, this shows that this system is a powerful tool that facilitates formulation tailoring and co-extrusion process setup at the earliest stage.


Asunto(s)
Química Farmacéutica/métodos , Desogestrel/análogos & derivados , Etinilestradiol/síntesis química , Química Farmacéutica/instrumentación , Preparaciones de Acción Retardada/síntesis química , Desogestrel/síntesis química , Combinación de Medicamentos , Composición de Medicamentos , Liberación de Fármacos , Vacio
18.
Drug Dev Ind Pharm ; 42(8): 1360-4, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26755129

RESUMEN

CONTEXT: Manufacturing solid low-dose pharmaceutical products has always the homogeneity challenge. In continuous manufacturing, there is the additional challenge of feeding active pharmaceutical ingredient (API) dry powder at low rates. This paper presents a method for feeding API particles into a continuous extrusion process using a suspension. The challenges for feeding and the product homogeneity are both addressed. OBJECTIVE: The objective of this study is to demonstrate the feasibility of manufacturing low-dose extrudates by feeding the API particles in a diluted anti-solvent suspension. MATERIALS AND METHODS: Extrudates with an Ibuprofen content of 0.021% and 0.043% (w/w) were prepared by feeding a 0.9% w/w suspension of Ibuprofen particles into a Coperion extruder. RESULTS AND DISCUSSION: The homogeneity (RSD) of extrudates was tested during a time span of 30 min and had values between 2% and 7%. CONCLUSION: Feeding particles in an anti-solvent suspension offers a simple feeding option for API and minor components which yield products of desired homogeneity. The liquid feeding approach offers a simplified process with enhanced process control possibilities.


Asunto(s)
Preparaciones Farmacéuticas/química , Tecnología Farmacéutica/métodos , Química Farmacéutica/métodos , Calor , Ibuprofeno/química , Polvos/química , Solventes/química , Suspensiones/química
19.
Drug Dev Ind Pharm ; 42(6): 977-84, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26489453

RESUMEN

In a previous study, a small-scale dynamic filtration device (SFD) was analyzed and the basic mechanisms governing the filtration process were characterized. The present work aims at improving the device's performance in terms of actual production. Various operation modes were tested in order to increase permeate flow and concentration factors (CF), while maintaining a fully continuous production mode. Both, a vacuum-enhanced and a pulsating operation mode, proved to be superior to the currently implemented open-operation mode. For example, for lactose, an increase of the CF could be achieved from 1.7 in open mode to 7.6 in pulsating operation mode. The investigated operation strategy enables process control systems to rapidly react to fluctuating feeds that may occur due to changes in upstream manufacturing steps. As a result, not only filtration performance in terms of permeate rate but also process flexibility can be significantly increased. Overall, vacuum-enhanced operation was shown to be most promising for integration into an industrial environment. The option to elevate achievable concentration factors, ease of flow monitoring as well as the ability to react to changes in the feed conditions allow for effective and efficient continuous small-scale filtration.


Asunto(s)
Filtración/métodos , Preparaciones Farmacéuticas/química , Tecnología Farmacéutica/métodos , Lactosa/química
20.
AAPS PharmSciTech ; 17(1): 68-77, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26206403

RESUMEN

This study focused on the development of flexible (i.e., deformable) multiple-unit pellets that feature (i) a prolonged drug release, (ii) drug abuse deterrence, and (iii) a minimal risk of alcohol-induced dose dumping (ADD). Deformable pellets were prepared via an advanced continuous one-step hot-melt extrusion (HME) technique, with the drug (i.e., antipyrine and codeine phosphate) fed as an aqueous solution into the molten matrix material (i.e., cornstarch, gum arabic, and xanthan). Formulations that had suitable mechanical characteristics (i.e., high compression strength) were coated with a flexible Aquacoat(®) ARC film to ensure prolonged release and to avoid ADD. The pellets were characterized in terms of their mechanical properties and in vitro drug release behavior in alcoholic media. All formulations were abuse deterrent: they had a high compression strength and grinding the pellets into powder was impossible. Since the pellets comprising gum arabic and xanthan as a matrix did not remain intact during dissolution testing, they had a very fast drug release rate. Cornstarch-based pellets that swelled but remained intact in the dissolution media had a slower drug release. Coated cornstarch-based pellets had a prolonged release over 8 h and resistance to dose dumping in 20 and 40% ethanol. Our results indicate that cornstarch-based pellets manufactured via the advanced HME process followed by coating are a promising formulation that makes tampering difficult due to a high compression strength combined with robustness in alcoholic media.


Asunto(s)
Celulosa/análogos & derivados , Química Farmacéutica/métodos , Composición de Medicamentos/métodos , Etanol/química , Preparaciones Farmacéuticas/química , Celulosa/química , Preparaciones de Acción Retardada/química , Liberación de Fármacos , Estabilidad de Medicamentos , Excipientes/química , Goma Arábiga/química , Calor , Polisacáridos Bacterianos/química , Polvos/química , Solubilidad , Almidón/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA